PRMT3和CARM1:癌症中的新兴表观遗传点
Jiezuo Huang1, Beining Qiao1, Yixin Yuan2
1College of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Journal of cellular and molecular medicine
|February 18, 2025
概括
蛋白质氨酸甲基转移酶 (PRMT),包括PRMT3和CARM1 (PRMT4),对于癌症的发展至关重要. 准这些酶可能会增强传统的癌症治疗方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 蛋白质氨酸甲基转移酶 (PRMT) 是参与细胞过程的重要酶.
- 异常的PRMT活性与各种癌症的发病和进展有关.
- PRMT3和CARM1 (PRMT4) 是I型的PRMT,可催化特定的甲基化模式.
研究的目的:
- 审查PRMT3和CARM1在癌症中的生物功能.
- 评估针对恶性瘤中PRMT3和CARM1的治疗潜力.
- 探索它们在癌症进展和治疗耐药性方面的作用.
主要方法:
- 在癌症中研究PRMT3和CARM1的文献综述.
- 对各种癌症类型的表达模式和功能角色的分析.
- 检查它们对瘤进展和治疗耐药性的参与.
主要成果:
- 在多种癌症中观察到PRMT3和CARM1的异常表达,包括肝细胞癌,结直肠癌,卵巢癌和子宫内膜癌.
- 这些酶在瘤的进展,进步和对治疗的抵抗中发挥着关键作用.
- 它们的甲基化活动会影响基因素和非基因素基质.
结论:
- PRMT3和CARM1是癌症生物学中的重要因素.
- 向PRMT3和CARM1为癌症治疗提供了一个有前途的治疗策略.
- 通过调节PRMT活性来提高传统疗法的疗效是一个潜在的新方向.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.5K
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K
